Prevention and risks

Vaccination, measles, HIV, hepatitis, laboratories, blood and surveillance: priorities for more preventive and better-prepared public health.

Peer learning and viral hepatitis elimination in Africa

Viral hepatitis in Africa: peer learning and the 2030 targets

7/7/2026Prevention and risks

Peer learning can support Africa’s hepatitis response. Progress towards the 2030 targets still depends on surveillance, sustainable funding and access to care.

National laboratory network in Morocco

Toward a National Laboratory Network

9/16/2025Prevention and risks

Analysis of Morocco’s national laboratory network project, covering health surveillance, public-private coordination, economic efficiency, international standards and health sovereignty.

Toward proactive public health in Morocco and Africa

Toward Proactive Public Health

9/9/2025Prevention and risks

Synthesis of the Global Health Diplomacy Symposium on the transition toward proactive public health in Morocco and Africa, built on prevention, risk reduction, regulation and regional cooperation.

Hepatitis B and C in Africa

Hepatitis in Africa: A Silent Epidemic

7/28/2025Prevention and risks

Analysis of hepatitis B and C in Africa and Morocco, covering underdiagnosis, stigma, vaccination, screening, antiviral access and public-health priorities.

Prevention spending and public-health return in Africa

How Much Does 1 Dirham Spent on Prevention Return?

7/22/2025Prevention and risks

Analysis of the health and economic return on prevention in Africa and Morocco, from vaccination and screening to chronic diseases, sustainable financing and regional examples.

Vaccine hesitancy and measles resurgence in Africa

Vaccines in a Trust Crisis: Understanding Hesitancy in Africa

7/8/2025Prevention and risks

An analysis of vaccine hesitancy in Africa and Morocco, covering declining trust, misinformation, falling booster uptake and the resurgence of measles.